📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

SGLT2 inhibitors in CKD and HFpEF: two new large trials and two new meta-analyses. (2023)

First Author: Mayne KJ

Attributed to: Adiposity and kidney disease: observations from large blood-based prospective cohorts across a wide range of different populations funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.5837/bjc.2023.003

PubMed Identifier: 37705832

Publication URI: http://europepmc.org/abstract/MED/37705832

Type: Journal Article/Review

Volume: 30

Parent Publication: The British journal of cardiology

Issue: 1

ISSN: 0969-6113